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showed significantly less injury in rats that received 
ketamine than in rats that did not (2.35 ± 1.14 vs  4.58 
± 0.50, P  < 0.0001). The distance traveled by a mark-
er, expressed as percentage of total intestinal length, 
in rats that received pentobarbital sodium was 20% ± 
2% in comparison with 25.9% ± 1.64% in rats that re-
ceived ketamine (P  = 0.017). BER was not statistically 
different between groups. 
CONCLUSION: Our results show that ketamine 
anesthesia is associated with diminished intestinal 
injury and abolishes the intestinal transit delay induced 
by ischemia/reperfusion.
© 2008 The WJG Press. All rights reserved.
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INTRODUCTION
Mesenteric ischemia is a clinical entity with a mortality 
rate between 60% and 100% that usually requires 
surgical resection of  the necrotic intestinal segment[1]. 
Although there have been advancements in the 
treatment of  ischemic injury, an ideal treatment has not 
been defined, and new options should be considered. A 
promising strategy is the use of  anesthetic and sedative 
agents that might exert protective effects on the injured 
tissue. Ketamine is an agent that has been recommended 
for this purpose in clinical situations of  sepsis, renal 
ischemia, cerebral ischemia and serious burn injuries[2-4]. 
The small intestine is very sensitive to ischemic 
insult[5]. Reperfusion causes additional damage through 
the release of  free radicals, pro-inflammatory cytokines, 
leukotrienes and other related products[6]. Intestinal 
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Abstract
AIM: To investigate the effects of ketamine anesthesia 
on the motility alterations and tissue injury caused by 
ischemia/reperfusion in rats.
METHODS: Thir ty male Wistar rats weighing 
200-250 g were used. Ischemia was induced by ob-
structing blood flow in 25% of the total small intesti-
nal length (ileum) with a vascular clamp for 45 min, 
after which either 60 min or 24 h of reperfusion was 
allowed. Rats were either anesthetized with pento-
barbital sodium (50 mg/kg) or ketamine (100 mg/kg). 
Control groups received sham surgery. After 60 min 
of reperfusion, the intestine was examined for mor-
phological alterations, and after 24 h intestinal basic 
electrical rhythm (BER) frequency was calculated, and 
intestinal transit determined in all groups.
RESULTS: The intestinal mucosa in rats that were 
anesthetized with ketamine showed moderate altera-
tions such as epithelial lifting, while ulceration and 
hemorrhage was observed in rats that received pento-
barbital sodium after 60 min of reperfusion. Quantita-
tive analysis of structural damage using the Chiu scale 
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ischemia/reperfusion (I/R) damages the intestinal 
mucosa and alters gastrointestinal motility[7]. The 
histological damage induced by I/R includes alterations 
in capillary permeability, mucosal barrier dysfunction, 
necrosis, epithelial shredding. The damage is reversed in 
a period of  approximately 24 h[8]. 
The NMDA (N-methyl-D-Aspartate) receptor 
family is a heterogeneous group of  excitatory ionotropic 
voltage and ligand gate dependent receptors. Ketamine 
is a parenteral anesthetic that non-competitively blocks 
the NMDA receptor[9]. It has been shown that ketamine 
protects various tissues from I/R injury, such as brain[10], 
myocardium[11] and skeletal muscle[12]. To the best of  
our knowledge, no previous studies have evaluated the 
effects of  ketamine on intestinal motility impairment 
and tissue damage induced by I/R.
MATERIALS AND METHODS
Procedures
Animal procedures were performed in accordance 
with the proper use and care of  laboratory animals. 
Experiments were performed on 30 male Wistar rats 
weighing 200-250 g. Animals were maintained under 
standard conditions, such as stable room temperature 
(24 ± 3℃), a 12 h light/12 h dark cycle, and access to 
commercial rat pellets and water ad libitum.
Animal models
Briefly, after anesthesia with pentobarbital sodium 
(Anestesal, Pfizer Inc, Mexico) or ketamine (Anesket, 
Pisa Agropecuaria, Hidalgo, Mexico), midline laparotomy 
was performed, and the small intestine was externalized 
and kept wrapped in humid sterile gauze to prevent 
dehydration. Rats were placed over a heating mat to 
maintain constant core temperature (37℃). Intestinal I/R 
was induced by selective clamping of  the vascular supply 
of  an ileum segment consisting of  25% of  the total 
intestinal length with microvascular clamps for 45 min 
(ischemia) followed by either 60 min or 24 h reperfusion. 
Ischemia was confirmed by absence of  pulsations as well 
as characteristic changes in intestinal coloration.
Thirty male Wistar rats were randomized into 3 
groups (n = 10) depending on the type of  anesthetic 
used. Each group was then divided into 2 subgroups. In 
subgroup A (n = 5), reperfusion lasted 60 min, and tissue 
was obtained for histological examination only, while 
in subgroup B (n = 5) it was extended to 24 h and the 
animals used to evaluate intestinal transit and intestinal 
electrical activity.
T h e c o n t r o l g r o u p ( n = 1 0 ) a n i m a l s we r e 
anesthetized with pentobarbital sodium (50 mg/kg) 
and sham-operated (only midline laparotomy and gut 
manipulation). In the SK group (n = 10) animals were 
anesthetized with pentobarbital sodium (50 mg/kg) 
and intestinal I/R was induced as described. In the 
KET group (n = 10) animals were anesthetized with 
ketamine (100 mg/kg) and intestinal I/R was induced as 
described.
Intestinal transit and basic electrical rhythm
In subgroup B, after 24 h of  reperfusion, animals were 
anesthetized with pentobarbital sodium (50 mg/kg), mid 
line laparotomy was performed, and 3 subserosal bipolar 
electrodes were used to record the electrical activity 
of  the ileum segment that had been subjected to I/R 
injury using a Power Lab 4/20T (ADInstruments, USA) 
equipped with 3 DC pre-amplifiers (ADInstruments, 
USA) to analyze and calculate intestinal Basic Electrical 
Rhythm (BER). Immediately after 30 min, 2 mL/kg of  
a non-absorbable charcoal solution marker was instilled 
through a canula into the proximal end of  the ileum 
segment studied, and after another 30 min the intestine 
was removed, and the distance traveled by the marker 
was registered. The distance traveled by a marker was 
then expressed as percentage of  total intestinal length 
from pylorus to cecum. This was used as an indicator of  
intestinal transit. Finally, tissue samples were obtained 
for morphologic examination.
    
Morphological examination
After the I/R procedure, rats were sacrificed by 
exsanguination from the aorta. Immediately, tissue 
samples were obtained and fixed in 10% neutral buffered 
formalin and embedded in paraffin, then 5 micrometer-
thick sections were stained with hematoxylin and eosin 
and examined under light microscope by a blinded 
pathologist. The Chiu scale[13] of  mucosal injury was used 
to evaluate the degree of  histological alteration on 10 
sections of  1 mm each to complete 1 cm per animal and 
then averaged. The scale consists of  values from 0 to 5, 
where 0 normal mucosa; 1, development of  sub epithelial 
(Gruenhagen’s) spaces; 2, extension of  the sub epithelial 
space with moderate epithelial lifting from the lamina 
propria; 3, extensive epithelial lifting with occasional 
denuded villi tips; 4, denuded villi with exposed lamina 
propria and dilated capillaries; and 5, disintegration of  the 
lamina propria, hemorrhage, and ulceration.
 
Statistical analysis
Data were analyzed with SPSS 11.0 (SPSS Inc. Software, 
Chicago, Illinois, USA) statistical software using one-way 
analysis of  variance (ANOVA) and with Tukey-Kramer 
test so as to determine comparison between groups, and 
differences between groups, respectively. All values were 
expressed as mean ± SD and P < 0.05 was considered 
statistically significant. 
RESULTS
Morphological examination
Structural changes in intestinal mucosa in rats of  
group KET A (ketamine anesthesia) showed moderate 
alteration such as epithelial lifting, while ulceration, 
hemorrhage and villi disintegration was observed in rats 
of  group SK A after 45 min of  ischemia and 60 min of  
reperfusion (Figure 1). The results of  the quantitative 
evaluation of  structural damage using the Chiu scale 
were as follows: control A 0.7 ± 0.45, SK A 4.58 ± 0.50 
and KET A 2.35 ± 1.14 (Figure 2). Damage in group 
KET A was significantly reduced in comparison with 
group SK A (P < 0.0001). However, the damage score in 
the KET A group did not reach control A group levels, 
indicating only moderate protection. The degree of  
mucosal damage after 24 h of  reperfusion (subgroups 
KET B and SK B) was the same as in control rats and 
showed no statistical significance. 
Intestinal transit and BER
The distance traveled by the marker, expressed as percent-
age of  total intestinal length, in subgroup SK B was 20% 
± 2% in comparison with subgroup KET B 25.9% ± 
1.64%. In the control B group, the distance traveled was 
27% ± 1.4% (Figure 3). Intestinal transit showed statisti-
cally significant delay in the SK subgroup compared with 
the other groups in this study (P = 0.0004). Group KET 
B showed no significant alteration in transit speed com-
pared to the control B group. The frequency of  the BER 
was not statistically different between any of  the groups 
after 24 h reperfusion: Control B 11.5 ± 1.1/min; SK B 
11.2 ± 0.5/min; KET B 11.75 ± 0.95/min.
DISCUSSION
The alterations on intestinal motility caused by I/R 
are directly related to the length of  both ischemia and 
reperfusion[14]. The functional alterations caused by I/R 
have been previously identified[15]. These changes consist 
of  reversible alterations in smooth muscle contractility 
and intestinal transit, as well as characteristic changes in 
electrical activity such as a decrease in BER frequency 
during ischemia[7,16]. Nitric oxide is one of  the mediators 
thought to participate in the changes caused by I/R on 
intestinal motility in the rat[17].   
The structural damage caused by ischemia is 
aggravated by the restitution of  blood f low. The 
physiopathology of  intestinal mucosal damage by I/R 
is not completely understood. But, it is believed that 
cytotoxic substances such as free radicals, nitric oxide, 
serotonin, complement, as well as neutrophil infiltration 
and nuclear transcription factors play important roles[18]. 
Macrophages have been also implicated in the initial 
damage caused by intestinal I/R[19]. I/R has also been 
shown to induce apoptosis[20]. Bacterial translocation 
and mucosal barrier dysfunction have been implicated 
in the damage caused by I/R in the gut[21]. This damage 
is also related to an increase in circulating levels of  pro-
inflammatory cytokines such as interleukin-6 and tumor 
necrosis factor alpha (TNF-alpha), liberated by the 
intestine itself[22].
Recently, anti-inflammatory properties of  ketamine 
Figure 1  A: Control A group showing normal mucosa; B: SK A. Changes in intestinal mucosa structure following 45 min of ischemia and 60 min reperfusion; C: KET A. 
Less damage was observed (all x 40).
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Figure 2  Bar diagram illustrating the Chiu score of mucosal injury after 60 min 
of reperfusion. Lower damage score was observed in a KET A group than in the 
SK A group. aP < 0.0001 vs control A; bP < 0.0001 vs KET A.
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Figure 3  Bar diagram illustrating the distance travelled by the marker, expressed 
as a percentage of total intestinal length from pylorus to cecum. Intestinal I/R 
caused transit delay that was corrected by the administration of ketamine as 
anesthetic. aP = 0.00019 vs control B; bP = 0.0004 vs KET B.
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have been described in various experimental models. 
Interleukin-1, 6, 8 and TNF-alpha levels are reduced 
after the administration of  ketamine[23-25]. Neutrophil 
adhesion, migration, and free radical release is inhibited 
by ketamine [26,27], as is nitric oxide production by 
macrophages[28]. Further studies are needed to determine 
whether one of  these effects is responsible for the 
mucosal protection against I/R that we observed in this 
study.
Glutamate is an excitatory neurotransmitter in 
the central nervous system, and it participates in the 
modulation of  intestinal function through the enteric 
nervous system, where NMDA receptors have been 
found[29]. It has been shown that the glutamate system 
is involved in the pathogenesis of  I/R in brain and 
intestine[30]. Glutamate release and NMDA receptor 
activation induces nitric oxide, and other free radicals that 
cause tissue injury[31]. Glutamate release during I/R could 
also cause toxicity in the enteric nervous system, which 
could cause motility alterations[32]. One recent study found 
that intestinal I/R causes myenteric plexus ganglion cell 
reduction and death[33]. This suggests that the NMDA 
receptor could be related to the functional alterations 
induced in the intestine by I/R. In one study, the NMDA 
antagonist MK-801 diminished nitric oxide production, 
and prevented the changes in the intestinal transit caused 
by intestinal ischemia/reperfusion[34]. We showed that 
ketamine, an NMDA receptor antagonist, also corrects the 
intestinal transit delay caused by intestinal I/R, but we did 
not find any changes in the frequency of  the BER after 
24 h of  reperfusion. Further studies are needed in order to 
determine whether our results are explained by ketamine 
acting as an NMDA receptor antagonist in the gut.
Ketamine protects the intestine against other types 
of  non-ischemic insults. Ketamine has been shown to 
protect the gut against endotoxemia induced injury in 
rats through diminished pro-inflammatory cytokine 
release[35]. Ketamine also decreased enterocyte apoptosis 
in a model of  thermal burn induced intestinal injury[36]. 
However, this is the first study to demonstrate that 
ketamine anesthesia reduces I/R induced injury in 
intestinal mucosa. 
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